Share

Novavax CEO talks receiving $384 million in CEPI funding for coronavirus vaccine candidate

Novavax CEO Stanley Erck discussed the biotech company's efforts to develop a Covid-19 vaccine, including millions in funding to help clinical trials and production.
08:31
Tue, May 12 20207:00 PM EDT